Indeed, CDK1 mutations (mostly SNPs) were identified in 0.74% of cancer patients, with the highest frequency in Uterine Corpus Endometrial Carcinoma (UCEC), Colon adenocarcinoma (COAD) and Skin Cutaneous Melanoma (SKCM) (Fig. 3a). Here, CDK1 is linked to cancer.